Transenterix (TRXC) Shares Gap Up to $2.12
Transenterix Inc (NYSEAMERICAN:TRXC) shares gapped up prior to trading on Tuesday . The stock had previously closed at $1.86, but opened at $2.12. Transenterix shares last traded at $2.31, with a volume of 4172700 shares traded.
Several research analysts recently issued reports on TRXC shares. Ladenburg Thalmann Financial Services set a $5.00 price target on shares of Transenterix and gave the stock a “buy” rating in a research note on Friday, October 20th. Stifel Nicolaus restated a “buy” rating and set a $4.00 price objective (up from $3.75) on shares of Transenterix in a research note on Monday, October 30th. Finally, BTIG Research restated a “hold” rating on shares of Transenterix in a research note on Monday. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $2.61.
In related news, CFO Joseph P. Slattery sold 333,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $2.93, for a total value of $975,690.00. Following the transaction, the chief financial officer now owns 440,974 shares of the company’s stock, valued at $1,292,053.82. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Todd Pope sold 600,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 18th. The stock was sold at an average price of $3.68, for a total transaction of $2,208,000.00. Following the completion of the transaction, the insider now directly owns 462,644 shares in the company, valued at approximately $1,702,529.92. The disclosure for this sale can be found here. In the last three months, insiders sold 1,462,609 shares of company stock worth $4,666,595.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/21/transenterix-trxc-shares-gap-up-to-2-12.html.
Transenterix Company Profile
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.